Skip to main content
Top
Published in: Abdominal Radiology 12/2017

01-12-2017 | Invited article

Collision and composite tumors; radiologic and pathologic correlation

Authors: Calvin T. Sung, Anup Shetty, Christine O. Menias, Roozbeh Houshyar, Shreya Chatterjee, Thomas K. Lee, Paul Tung, Mohammed Helmy, Chandana Lall

Published in: Abdominal Radiology | Issue 12/2017

Login to get access

Abstract

The terms composite and collision tumors have been used interchangeably throughout radiological literature. Both composite and collision tumors involve two morphologically and immunohistochemically distinct neoplasms coexisting within a single organ. However, collision tumors lack the histological cellular intermingling seen in composite tumors. Composite tumors often arise from a common driver mutation that induces a divergent histology from a common neoplastic source while collision tumors may arise from coincidental neoplastic change. The purpose of this review is to provide an overview of abdominal composite and collision tumors by discussing hallmark radiographic and pathological presentations of rare hepatic, renal, and adrenal case studies. A better understanding of the presentation of each lesion is imperative for proper recognition, diagnosis, and management of these unique tumor presentations.
Literature
3.
go back to reference Michalinos A, Constantinidou A, Kontos M (2015) Gastric collision tumors: an insight into their origin and clinical significance. Gastroenterol Res Pract 2015:314158CrossRefPubMedPubMedCentral Michalinos A, Constantinidou A, Kontos M (2015) Gastric collision tumors: an insight into their origin and clinical significance. Gastroenterol Res Pract 2015:314158CrossRefPubMedPubMedCentral
4.
go back to reference Aggarwal N, et al. (2012) Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma. Pathol Res Pract 208(1):50–52CrossRefPubMed Aggarwal N, et al. (2012) Tumor-to-tumor metastasis: case report of a pulmonary adenocarcinoma metastatic to a clear cell renal cell carcinoma. Pathol Res Pract 208(1):50–52CrossRefPubMed
5.
go back to reference Anani W, et al. (2014) A series of collision tumors in the genitourinary tract with a review of the literature. Pathol Res Pract 210(4):217–223CrossRefPubMed Anani W, et al. (2014) A series of collision tumors in the genitourinary tract with a review of the literature. Pathol Res Pract 210(4):217–223CrossRefPubMed
7.
go back to reference Brandwein-Gensler M, Urken M, Wang B (2004) Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck 26(7):637–641CrossRefPubMed Brandwein-Gensler M, Urken M, Wang B (2004) Collision tumor of the thyroid: a case report of metastatic liposarcoma plus papillary thyroid carcinoma. Head Neck 26(7):637–641CrossRefPubMed
8.
go back to reference Chin S, Kim Z (2014) Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature. Int J Clin Exp Pathol 7(11):8290–8294PubMedPubMedCentral Chin S, Kim Z (2014) Sarcomatoid combined hepatocellular-cholangiocarcinoma: a case report and review of literature. Int J Clin Exp Pathol 7(11):8290–8294PubMedPubMedCentral
9.
go back to reference Shetty AS, et al. (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39(2):310–322CrossRefPubMed Shetty AS, et al. (2014) Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma. Abdom Imaging 39(2):310–322CrossRefPubMed
10.
go back to reference Jarnagin WR, et al. (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94(7):2040–2046CrossRefPubMed Jarnagin WR, et al. (2002) Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer 94(7):2040–2046CrossRefPubMed
11.
go back to reference Lee SD, et al. (2014) Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat Dis Int 13(6):594–601CrossRefPubMed Lee SD, et al. (2014) Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery. Hepatobiliary Pancreat Dis Int 13(6):594–601CrossRefPubMed
12.
go back to reference Lee JH, et al. (2011) Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 45(1):69–75PubMed Lee JH, et al. (2011) Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol 45(1):69–75PubMed
13.
go back to reference Yin X, et al. (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19(9):2869–2876CrossRefPubMed Yin X, et al. (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19(9):2869–2876CrossRefPubMed
14.
go back to reference Panjala C, et al. (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10(5):1263–1267CrossRefPubMed Panjala C, et al. (2010) The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant 10(5):1263–1267CrossRefPubMed
15.
go back to reference Liu CL, et al. (2003) Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 138(1):86–90CrossRefPubMed Liu CL, et al. (2003) Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg 138(1):86–90CrossRefPubMed
16.
go back to reference Wang J, Wang F, Kessinger A (2010) Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010:7 Wang J, Wang F, Kessinger A (2010) Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol 2010:7
17.
go back to reference Chi M, et al. (2012) Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res 5(6):199–202PubMedPubMedCentral Chi M, et al. (2012) Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res 5(6):199–202PubMedPubMedCentral
18.
go back to reference Sapisochin G, et al. (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17(8):934–942CrossRefPubMed Sapisochin G, et al. (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17(8):934–942CrossRefPubMed
19.
go back to reference Theise N, et al. (2010) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) Who classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, pp 225–227 Theise N, et al. (2010) Combined hepatocellular-cholangiocarcinoma. In: Bosman FT, Carneiro F, Hruban RH, Theise ND (eds) Who classification of tumours of the digestive system. Lyon: International Agency for Research on Cancer, pp 225–227
20.
go back to reference Purysko AS, et al. (2012) LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 32(7):1977–1995CrossRefPubMed Purysko AS, et al. (2012) LI-RADS: a case-based review of the new categorization of liver findings in patients with end-stage liver disease. Radiographics 32(7):1977–1995CrossRefPubMed
22.
23.
go back to reference Akiba J, et al. (2013) Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 37(4):496–505CrossRefPubMed Akiba J, et al. (2013) Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 37(4):496–505CrossRefPubMed
24.
go back to reference Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62(8):1271–1278CrossRefPubMed Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62(8):1271–1278CrossRefPubMed
25.
go back to reference Yang JD, et al. (2011) Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9(7):617–623CrossRefPubMed Yang JD, et al. (2011) Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol 9(7):617–623CrossRefPubMed
26.
go back to reference Sempoux C, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31(1):49–60CrossRefPubMed Sempoux C, et al. (2011) Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis 31(1):49–60CrossRefPubMed
28.
go back to reference Xu J, et al. (2016) Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases. Zhonghua Bing Li Xue Za Zhi 45(3):175–179PubMed Xu J, et al. (2016) Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases. Zhonghua Bing Li Xue Za Zhi 45(3):175–179PubMed
29.
go back to reference Zhang F, et al. (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52(2):224–232CrossRefPubMed Zhang F, et al. (2008) Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology 52(2):224–232CrossRefPubMed
31.
go back to reference Allaire GS, et al. (1988) Bile duct adenoma. a study of 152 cases. Am J Surg Pathol 12(9):708–715CrossRefPubMed Allaire GS, et al. (1988) Bile duct adenoma. a study of 152 cases. Am J Surg Pathol 12(9):708–715CrossRefPubMed
33.
go back to reference Aoki K, et al. (1993) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18(5):1090–1095CrossRefPubMed Aoki K, et al. (1993) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology 18(5):1090–1095CrossRefPubMed
34.
go back to reference Chen LD, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753CrossRefPubMed Chen LD, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20(3):743–753CrossRefPubMed
35.
go back to reference Leoni S, et al. (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105(3):599–609CrossRefPubMed Leoni S, et al. (2010) The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. Am J Gastroenterol 105(3):599–609CrossRefPubMed
36.
go back to reference Sherman M (2010) The radiological diagnosis of hepatocellular carcinoma. In: Am J Gastroenterol. United States. p 610–612. Sherman M (2010) The radiological diagnosis of hepatocellular carcinoma. In: Am J Gastroenterol. United States. p 610–612.
37.
go back to reference Ros PR, et al. (1986) Mesenchymal hamartoma of the liver: radiologic-pathologic correlation. Radiology 158(3):619–624CrossRefPubMed Ros PR, et al. (1986) Mesenchymal hamartoma of the liver: radiologic-pathologic correlation. Radiology 158(3):619–624CrossRefPubMed
38.
go back to reference Kim KA, et al. (2006) Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 187(5):W481–W489CrossRefPubMed Kim KA, et al. (2006) Unusual mesenchymal liver tumors in adults: radiologic-pathologic correlation. AJR Am J Roentgenol 187(5):W481–W489CrossRefPubMed
39.
go back to reference Lai FM, et al. (1996) Hepatic mesenchymal hamartoma: a case report and radiological findings. Singap Med J 37(2):226–228 Lai FM, et al. (1996) Hepatic mesenchymal hamartoma: a case report and radiological findings. Singap Med J 37(2):226–228
43.
go back to reference Cornette J, et al. (2009) Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature. Fetal Diagn Ther 25(2):196–202CrossRefPubMed Cornette J, et al. (2009) Mesenchymal hamartoma of the liver: a benign tumor with deceptive prognosis in the perinatal period. Case report and review of the literature. Fetal Diagn Ther 25(2):196–202CrossRefPubMed
44.
go back to reference Anil G, Fortier M, Low Y (1001) Cystic hepatic mesenchymal hamartoma: the role of radiology in diagnosis and perioperative management. Br J Radiol 2011(84):e91–e94 Anil G, Fortier M, Low Y (1001) Cystic hepatic mesenchymal hamartoma: the role of radiology in diagnosis and perioperative management. Br J Radiol 2011(84):e91–e94
45.
46.
go back to reference Lall C, et al. (2015) Renal collision and composite tumors: imaging and pathophysiology. Urology 86(6):1159–1164CrossRefPubMed Lall C, et al. (2015) Renal collision and composite tumors: imaging and pathophysiology. Urology 86(6):1159–1164CrossRefPubMed
47.
go back to reference Lopez-Beltran A, et al. (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798–805CrossRefPubMed Lopez-Beltran A, et al. (2006) 2004 WHO classification of the renal tumors of the adults. Eur Urol 49(5):798–805CrossRefPubMed
48.
go back to reference Waldert M, et al. (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57(4):661–665CrossRefPubMed Waldert M, et al. (2010) Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol 57(4):661–665CrossRefPubMed
49.
go back to reference Su D, Singer EA, Srinivasan R (2015) Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology. Curr Opin Oncol 27(3):217–223CrossRefPubMed Su D, Singer EA, Srinivasan R (2015) Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology. Curr Opin Oncol 27(3):217–223CrossRefPubMed
50.
go back to reference Mucciardi G, et al. (2015) Transitional cell carcinoma of the renal pelvis with synchronous ipsilateral papillary renal cell carcinoma: case report and review. Urol Case Rep 3(4):93–95CrossRefPubMedPubMedCentral Mucciardi G, et al. (2015) Transitional cell carcinoma of the renal pelvis with synchronous ipsilateral papillary renal cell carcinoma: case report and review. Urol Case Rep 3(4):93–95CrossRefPubMedPubMedCentral
51.
go back to reference Upton MP, et al. (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28(5):488–495CrossRefPubMed Upton MP, et al. (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28(5):488–495CrossRefPubMed
52.
go back to reference Escudier B, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134CrossRefPubMed Escudier B, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356(2):125–134CrossRefPubMed
53.
go back to reference Polascik TJ, Bostwick DG, Cairns P (2002) Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60(6):941–946CrossRefPubMed Polascik TJ, Bostwick DG, Cairns P (2002) Molecular genetics and histopathologic features of adult distal nephron tumors. Urology 60(6):941–946CrossRefPubMed
54.
go back to reference Sukosd F, et al. (2003) Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63(2):455–457PubMed Sukosd F, et al. (2003) Deletion of chromosome 3p14.2-p25 involving the VHL and FHIT genes in conventional renal cell carcinoma. Cancer Res 63(2):455–457PubMed
55.
go back to reference Gurel S, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol 19(4):304–311PubMed Gurel S, et al. (2013) Subtypes of renal cell carcinoma: MRI and pathological features. Diagn Interv Radiol 19(4):304–311PubMed
56.
go back to reference Sun MR, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed Sun MR, et al. (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250(3):793–802CrossRefPubMed
57.
go back to reference Vargas HA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264(3):779–788CrossRefPubMed Vargas HA, et al. (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264(3):779–788CrossRefPubMed
58.
go back to reference Gordetsky J, Zarzour J (2016) Correlating preoperative imaging with histologic subtypes of renal cell carcinoma and common mimickers. Curr Urol Rep 17(7):52CrossRefPubMed Gordetsky J, Zarzour J (2016) Correlating preoperative imaging with histologic subtypes of renal cell carcinoma and common mimickers. Curr Urol Rep 17(7):52CrossRefPubMed
59.
60.
go back to reference Davidson AJ, et al. (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed Davidson AJ, et al. (1993) Renal oncocytoma and carcinoma: failure of differentiation with CT. Radiology 186(3):693–696CrossRefPubMed
61.
go back to reference Rosenkrantz AB, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427CrossRefPubMed Rosenkrantz AB, et al. (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol 195(6):W421–W427CrossRefPubMed
62.
go back to reference Perez-Ordonez B, et al. (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21(8):871–883CrossRefPubMed Perez-Ordonez B, et al. (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 21(8):871–883CrossRefPubMed
63.
go back to reference Harmon WJ, King BF, Lieber MM (1996) Renal oncocytoma: magnetic resonance imaging characteristics. J Urol 155(3):863–867CrossRefPubMed Harmon WJ, King BF, Lieber MM (1996) Renal oncocytoma: magnetic resonance imaging characteristics. J Urol 155(3):863–867CrossRefPubMed
64.
go back to reference Rosenkrantz AB, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195(5):W344–W351CrossRefPubMed Rosenkrantz AB, et al. (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR Am J Roentgenol 195(5):W344–W351CrossRefPubMed
65.
go back to reference Taouli B, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251(2):398–407CrossRefPubMed Taouli B, et al. (2009) Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Radiology 251(2):398–407CrossRefPubMed
66.
go back to reference Mugiya S, et al. (2004) Ultrasonographic features of chromophobe cell renal carcinoma. Hinyokika Kiyo 50(12):865–868PubMed Mugiya S, et al. (2004) Ultrasonographic features of chromophobe cell renal carcinoma. Hinyokika Kiyo 50(12):865–868PubMed
67.
go back to reference Kondo T, et al. (2004) Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 11(10):817–824CrossRefPubMed Kondo T, et al. (2004) Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies. Int J Urol 11(10):817–824CrossRefPubMed
68.
go back to reference Shuch B, et al. (2012) Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist 17(1):46–54CrossRefPubMedPubMedCentral Shuch B, et al. (2012) Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies. Oncologist 17(1):46–54CrossRefPubMedPubMedCentral
69.
go back to reference de Peralta-Venturina M, et al. (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284CrossRefPubMed de Peralta-Venturina M, et al. (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284CrossRefPubMed
70.
go back to reference Cheville JC, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRefPubMed Cheville JC, et al. (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28(4):435–441CrossRefPubMed
71.
go back to reference Shuch B, et al. (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology–is up-front resection indicated and if not, is it avoidable? J Urol 182(5):2164–2171CrossRefPubMedPubMedCentral Shuch B, et al. (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology–is up-front resection indicated and if not, is it avoidable? J Urol 182(5):2164–2171CrossRefPubMedPubMedCentral
72.
go back to reference Schieda N, et al. (2015) Diagnosis of sarcomatoid renal cell carcinoma with CT: evaluation by qualitative imaging features and texture analysis. AJR Am J Roentgenol 204(5):1013–1023CrossRefPubMed Schieda N, et al. (2015) Diagnosis of sarcomatoid renal cell carcinoma with CT: evaluation by qualitative imaging features and texture analysis. AJR Am J Roentgenol 204(5):1013–1023CrossRefPubMed
73.
go back to reference Sant GR, et al. (1984) Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology 24(3):293–296CrossRefPubMed Sant GR, et al. (1984) Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology 24(3):293–296CrossRefPubMed
74.
go back to reference Kloos RT, et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484PubMed Kloos RT, et al. (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460–484PubMed
76.
go back to reference Ctvrtlik F, et al. (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69(2):243–252CrossRefPubMed Ctvrtlik F, et al. (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69(2):243–252CrossRefPubMed
77.
go back to reference Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29(5):1333–1351CrossRefPubMed Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29(5):1333–1351CrossRefPubMed
78.
go back to reference Otal P, et al. (1999) Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19(3):569–581CrossRefPubMed Otal P, et al. (1999) Imaging features of uncommon adrenal masses with histopathologic correlation. Radiographics 19(3):569–581CrossRefPubMed
79.
go back to reference Johnson PT, Horton KM, Fishman EK (2009) Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 29(5):1319–1331CrossRefPubMed Johnson PT, Horton KM, Fishman EK (2009) Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 29(5):1319–1331CrossRefPubMed
80.
go back to reference Piotrowski Z, et al. (2015) Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology 85(3):e17–e18CrossRefPubMed Piotrowski Z, et al. (2015) Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology 85(3):e17–e18CrossRefPubMed
81.
go back to reference Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40(5):561–576CrossRef Reznek RH, Armstrong P (1994) The adrenal gland. Clin Endocrinol 40(5):561–576CrossRef
82.
go back to reference Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202(2):517–521CrossRefPubMed Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202(2):517–521CrossRefPubMed
Metadata
Title
Collision and composite tumors; radiologic and pathologic correlation
Authors
Calvin T. Sung
Anup Shetty
Christine O. Menias
Roozbeh Houshyar
Shreya Chatterjee
Thomas K. Lee
Paul Tung
Mohammed Helmy
Chandana Lall
Publication date
01-12-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 12/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1200-x

Other articles of this Issue 12/2017

Abdominal Radiology 12/2017 Go to the issue